Photo: Depositphotos
May 3, 2025, 12:04
Pierre Blanchard: V04 randomized study on Gem/Cis chemoradiation for bladder cancer at ESTRO25
Pierre Blanchard, Radiation Oncology Clinical Section Chief at Gustave Roussy Cancer Institute, posted on X:
“V04 randomized study on Gem/Cis chemoradiation for bladder cancer presented by Morgan Michalet.
Surprising lower survival (NS but small cohort) that may be a cause of concern. Related to higher metastases in Gem/Cis group.”
ESTRO 2025 Live Updates on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 5, 2025, 20:31
Jul 5, 2025, 20:15
Jul 5, 2025, 20:00
Jul 5, 2025, 19:18
Jul 5, 2025, 18:52
Jul 5, 2025, 18:38